Biosensing Instrument

10/21/2026

Check out this paper from University of Missouri-Kansas City on "Exploring Multivalency in the Development of Anti-PD-L1 Peptides for Cancer Immunotherapy"

Read it here: https://link.springer.com/article/10.1007/s11095-024-03803-1

Purpose The PD-1/PD-L1 pathway is one of the most effective immune checkpoint pathways utilized for cancer immunotherapy. Despite the success of anti-PD-1/PD-L1 mAbs, there is growing interest in developing low molecular weight anti-PD-1/PD-1 agents, such as peptides, because of their improved tumor...

10/15/2026

Eurofins DiscoverX will be hosting a Webinar on "Dissecting the Biology Behind Antibody-Drug Conjugates" on Thursday, Nov. 12. If you're interested in learning more about the applications of in come check it out!

Register here: https://www.drugdiscoverynews.com/dissecting-the-biology-behind-antibody-drug-conjugates-17523

09/22/2026

Check out our latest application note on "Kinetic Analysis of NGF-Differentiated PC12 Neuronal Cells on an Chip"

Read it here: https://biosensingusa.com/application-notes/application-note-183-kinetic-analysis-of-ngf-differentiated-pc12-neuronal-cells-on-an-sprm-chip/

09/09/2026

Check out our latest Application Note on Label-Free Kinetic Analysis of Anti-TCR Binding to Jurkat T Cells Using

Read it here: https://biosensingusa.com/application-notes/application-note-182-label-free-kinetic-analysis-of-anti-tcr-binding-to-jurkat-t-cells-using-surface-plasmon-resonance-microscopy/

08/27/2026

Biosensing Instrument will be at Discovery on Target 2026! Come see us at Booth #307 to say hi and learn more about our award winning technology.

Learn more about Discovery on Target 2026 here: https://www.discoveryontarget.com/

08/19/2026

Check out this paper from Yixian Wang at California State University, Los Angeles on accessing real-time interaction between antimicrobial liposomes and live Staphylococcus epidermidis using

Read it here: https://doi.org/10.1016/j.biosx.2026.100792

08/12/2026

Check out our newest Application Note on Agonist and Antagonist Peptide Binding Interaction Kinetics with GLP-1R!

Read it here: https://biosensingusa.com/application-notes/application-note-181-in-vitro-characterization-of-agonist-and-antagonist-peptide-binding-interaction-kinetics-to-glp-1r-in-hek293t-cells-using-spr-microscopy/

07/22/2026

Check out our latest AppNote on analysis of Malaria antigens!

Read more: https://biosensingusa.com/application-notes/application-note-180-surface-plasmon-resonance-analysis-of-chemically-synthesized-cyclic-malaria-antigen-pfama1-domain-i-binding-to-pfron2/

07/15/2026

Check out this paper on "Agonist and Antagonist Peptide Binding Interaction Kinetics" by our lovely team Miyuki Thirumurthy, Jesus Aguilar Diaz de leon, and Nguyen (Win) Ly, PhD as well as Shuchong Pan from Mayo Clinic

Read it here:

The glucagon peptide 1 receptor (GLP-1R), a class-B-type G protein-coupled receptor (GPCR), is a key therapeutic target for many metabolic disorders, including obesity and type 2 diabetes, due to its central role in glucose homeostasis and insulin secretion. Despite its pharmacological importance, s...

06/30/2026

Check out this paper by Kris Borzilleri, Jonathan Brooks, and Felix Vajdos "Discovery of Potent and Brain-Penetrant Inverse Agonists for GPR61, an Orphan G Protein-Coupled Receptor"!

Read it here:

GPR61 is a class A orphan G protein-coupled receptor (GPCR) that is predominantly expressed in the pituitary gland and appetite-regulating centers of the brain. Genome-wide association analysis, epigenetic analysis, and animal model data have suggested that GPR61 could be a potential therapeutic tar...